Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.42
-0.47 (-2.15%)
May 29, 2026, 4:00 PM EDT - Market closed
Innoviva Revenue
Innoviva had revenue of $97.99M in the quarter ending March 31, 2026, with 10.56% growth. This brings the company's revenue in the last twelve months to $420.69M, up 13.75% year-over-year. In the year 2025, Innoviva had annual revenue of $411.33M with 14.67% growth.
Revenue (ttm)
$420.69M
Revenue Growth
+13.75%
P/S Ratio
3.76
Revenue / Employee
$2,645,849
Employees
159
Market Cap
1.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 411.33M | 52.62M | 14.67% |
| Dec 31, 2024 | 358.71M | 48.25M | 15.54% |
| Dec 31, 2023 | 310.46M | -20.88M | -6.30% |
| Dec 31, 2022 | 331.34M | -60.53M | -15.45% |
| Dec 31, 2021 | 391.87M | 55.07M | 16.35% |
| Dec 31, 2020 | 336.79M | 75.78M | 29.03% |
| Dec 31, 2019 | 261.02M | 12.00K | - |
| Dec 31, 2018 | 261.00M | 43.79M | 20.16% |
| Dec 31, 2017 | 217.22M | 83.65M | 62.63% |
| Dec 31, 2016 | 133.57M | 79.62M | 147.58% |
| Dec 31, 2015 | 53.95M | 45.52M | 539.74% |
| Dec 31, 2014 | 8.43M | 3.90M | 86.08% |
| Dec 31, 2013 | 4.53M | -1.08M | -19.26% |
| Dec 31, 2012 | 5.61M | -18.90M | -77.10% |
| Dec 31, 2011 | 24.51M | 289.00K | 1.19% |
| Dec 31, 2010 | 24.22M | -151.00K | -0.62% |
| Dec 31, 2009 | 24.37M | 1.28M | 5.53% |
| Dec 31, 2008 | 23.10M | 1.09M | 4.97% |
| Dec 31, 2007 | 22.00M | 2.42M | 12.33% |
| Dec 31, 2006 | 19.59M | 7.53M | 62.49% |
| Dec 31, 2005 | 12.05M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 427.68M |
| AnaptysBio | 232.39M |
| Nuvation Bio | 143.05M |
| Vir Biotechnology | 65.50M |
| Immatics | 43.00M |
| Precigen | 31.60M |
| AtaiBeckley | 3.49M |
| Inhibrx Biosciences | 1.30M |
INVA News
- 18 days ago - Innoviva management to meet with BTIG - TheFly
- 18 days ago - Innoviva management to meet with BTIG - TheFly
- 24 days ago - Innoviva price target raised to $42 from $35 at BTIG - TheFly
- 24 days ago - Innoviva reports Q1 EPS $2.22 vs (74c) last year - TheFly
- 25 days ago - Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire
- 25 days ago - Innoviva Earnings release: Q1 2026 - Filings
- 25 days ago - Innoviva Quarterly report: Q1 2026 - Filings
- 7 weeks ago - 3 Bargain-Cheap Small Caps Worth a Second Look - MarketBeat